Skip to main content
. 2017 Dec 28;9(4):5216–5232. doi: 10.18632/oncotarget.23749

Figure 1. 20-223 exhibits anti-tumor activity in a colorectal cancer xenograft model.

Figure 1

(A) Growth Inhibition of GEO cells after 72 hour treatment with 20-223. (B) Schematic representation of CRC xenograft model using GEO-GFP cells. (C) Average tumor volume comparison of DMSO and 20-223 treated tumors throughout the study. (D) Average GFP Flurorescence in DMSO and 20-223 treated tumors. (E) Average tumor weight of DMSO and 20-223 treated tumors.